Go Pro
→ Trump's New Dollar (From Porter & Company) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Celcuity, Inc. stock logo
CELC
Celcuity
$91.98
+3.3%		$94.66
$44.42
▼
$151.02
$4.36B0.21757,183 shs1.16 million shs
10 Stocks Powering The Next AI Boom Cover
10 Stocks Powering The Next AI Boom

The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation.

Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Celcuity, Inc. stock logo
CELC
Celcuity
+0.70%-1.91%+3.10%-2.58%+73.84%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Celcuity, Inc. stock logo
CELC
Celcuity
$91.98
+3.3%		$94.66
$44.42
▼
$151.02
$4.36B0.21757,183 shs1.16 million shs
10 Stocks Powering The Next AI Boom Cover
10 Stocks Powering The Next AI Boom

The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation.

Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Celcuity, Inc. stock logo
CELC
Celcuity
+0.70%-1.91%+3.10%-2.58%+73.84%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Celcuity, Inc. stock logo
CELC
Celcuity
2.82
Moderate Buy$154.5568.02% Upside

Current Analyst Ratings Breakdown

Latest CELC Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
8/17/2026
Celcuity, Inc. stock logo
CELC
Celcuity
Guggenheim logo
Guggenheim
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetBuy$165.00 ➝ $175.00
8/17/2026
Celcuity, Inc. stock logo
CELC
Celcuity
Citigroup Inc. logo
Citigroup
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingMarket Outperform
8/17/2026
Celcuity, Inc. stock logo
CELC
Celcuity
Citizens Jmp logo
Citizens Jmp
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingMarket Outperform$177.00
8/14/2026
Celcuity, Inc. stock logo
CELC
Celcuity
HC Wainwright logo
HC Wainwright
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingBuy$155.00
8/14/2026
Celcuity, Inc. stock logo
CELC
Celcuity
Stifel Nicolaus logo
Stifel Nicolaus
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower Price TargetBuy$175.00 ➝ $150.00
8/14/2026
Celcuity, Inc. stock logo
CELC
Celcuity
Needham & Company LLC logo
Needham & Company LLC
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower Price TargetBuy$157.00 ➝ $140.00
7/15/2026
Celcuity, Inc. stock logo
CELC
Celcuity
Craig Hallum logo
Craig Hallum
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingBuy$178.00
7/15/2026
Celcuity, Inc. stock logo
CELC
Celcuity
HC Wainwright logo
HC Wainwright
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetBuy$145.00 ➝ $155.00
7/15/2026
Celcuity, Inc. stock logo
CELC
Celcuity
Citigroup Inc. logo
Citigroup
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingOutperform
7/15/2026
Celcuity, Inc. stock logo
CELC
Celcuity
Citizens Jmp logo
Citizens Jmp
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetMarket Outperform$160.00 ➝ $177.00
(Data available from 9/1/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Celcuity, Inc. stock logo
CELC
Celcuity
N/AN/AN/AN/A$2.17 per shareN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Celcuity, Inc. stock logo
CELC
Celcuity
-$177.04M-$4.30N/AN/AN/AN/A-350.78%-41.54%11/11/2026 (Estimated)

Latest CELC Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/13/2026Q2 2026
Celcuity, Inc. stock logo
CELC
Celcuity
-$1.16-$1.44-$0.28-$1.44$4.42 millionN/A
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Celcuity, Inc. stock logo
CELC
Celcuity
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Celcuity, Inc. stock logo
CELC
Celcuity
6.04
8.93
8.93

Institutional Ownership

CompanyInstitutional Ownership
Celcuity, Inc. stock logo
CELC
Celcuity
63.33%

Insider Ownership

CompanyInsider Ownership
Celcuity, Inc. stock logo
CELC
Celcuity
13.33%
CompanyEmployeesShares OutstandingFree FloatOptionable
Celcuity, Inc. stock logo
CELC
Celcuity
4048.93 million42.41 millionOptionable

Recent News About These Companies

Celcuity To Participate in Upcoming Investor Conferences
September 1 at 8:30 AM  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/09/01/3354143/0/en/celcuity-to-participate-in-upcoming-investor-conferences.html
Man Group plc Makes New $3.02 Million Investment in Celcuity, Inc. $CELC
September 1 at 4:56 AM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-man-group-plc-makes-new-302-million-investment-in-celcuity-inc-celc-2026-09-01/
Alyeska Investment Group L.P. Acquires 95,664 Shares of Celcuity, Inc. $CELC
September 1 at 3:11 AM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-alyeska-investment-group-lp-acquires-95664-shares-of-celcuity-inc-celc-2026-09-01/
Freestone Grove Partners LP Takes $7.10 Million Position in Celcuity, Inc. $CELC
August 29 at 4:27 AM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-freestone-grove-partners-lp-takes-710-million-position-in-celcuity-inc-celc-2026-08-29/
Jefferies Financial Group Inc. Invests $9.34 Million in Celcuity, Inc. $CELC
August 28, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-jefferies-financial-group-inc-invests-934-million-in-celcuity-inc-celc-2026-08-28/
Gedatolisib sNDA Submitted to FDA in PIK3CA-Mutant Advanced Breast Cancer
August 27, 2026  |  targetedonc.comT
Celcuity (CELC): Landmark Approval Collides With A Costly Launch
August 27, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/healthcare/articles/celcuity-celc-landmark-approval-collides-202745708.html
Celcuity Submits Supplemental NDA for REVTORPYK in PIK3CA-Mutant Breast Cancer
August 27, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/healthcare/articles/celcuity-submits-supplemental-nda-revtorpyk-125910412.html
Connor Clark & Lunn Investment Management Ltd. Buys Shares of 91,449 Celcuity, Inc. $CELC
August 27, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-connor-clark-lunn-investment-management-ltd-buys-shares-of-91449-celcuity-inc-celc-2026-08-27/
Artia Global Partners LP Purchases New Position in Celcuity, Inc. $CELC
August 27, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-artia-global-partners-lp-purchases-new-position-in-celcuity-inc-celc-2026-08-27/
Celcuity Submits sNDA to FDA for REVTORPYK™ (gedatolisib) for HR+/HER2-, PIK3CA Mutant Locally Advanced or Metastatic Breast Cancer
August 26, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/08/26/3351327/0/en/celcuity-submits-snda-to-fda-for-revtorpyk-gedatolisib-for-hr-her2-pik3ca-mutant-locally-advanced-or-metastatic-breast-cancer.html
Deutsche Bank AG Invests $4.14 Million in Celcuity, Inc. $CELC
August 26, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-deutsche-bank-ag-invests-414-million-in-celcuity-inc-celc-2026-08-26/
Nan Fung Group Holdings Ltd Purchases Shares of 28,300 Celcuity, Inc. $CELC
August 25, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-nan-fung-group-holdings-ltd-purchases-shares-of-28300-celcuity-inc-celc-2026-08-25/
Celcuity (CELC) Q2 2026 Earnings Call Transcript
August 20, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/healthcare/articles/celcuity-celc-q2-2026-earnings-211455512.html
E Fund Management Co. Ltd. Purchases New Holdings in Celcuity, Inc. $CELC
August 20, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-e-fund-management-co-ltd-purchases-new-holdings-in-celcuity-inc-celc-2026-08-20/
Celcuity Makes Monumental Progress in Advancing Clinical Development of Gedatolisib for HR-Positive, HER2-Negative Advanced Breast Cancer
August 18, 2026  |  news.themarketisopen.comN
Celcuity's (CELC) "Market Outperform" Rating Reiterated at Citizens Jmp
August 17, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/celcuitys-celc-market-outperform-rating-reiterated-at-citizens-jmp-2026-08-17/
How Investors May Respond To Celcuity (CELC) Winning FDA Nod For Revtopik Amid Wider Quarterly Loss
August 16, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/healthcare/articles/investors-may-respond-celcuity-celc-041606313.html
Wells Fargo Reaffirms Their Buy Rating on Celcuity (CELC)
August 15, 2026  |  theglobeandmail.comhttps://www.theglobeandmail.com/investing/markets/stocks/CELC/pressreleases/3866246/wells-fargo-reaffirms-their-buy-rating-on-celcuity-celc/
Celcuity (NASDAQ:CELC) Stock Rating Lowered by Wall Street Zen
August 15, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/celcuity-nasdaqcelc-stock-rating-lowered-by-wall-street-zen-2026-08-15/
Celcuity (NASDAQ:CELC) Releases Quarterly Earnings Results, Misses Estimates By $0.28 EPS
August 14, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/celcuity-nasdaqcelc-releases-quarterly-earnings-results-misses-estimates-by-028-eps-2026-08-14/

New MarketBeat Followers Over Time

Media Sentiment Over Time

Celcuity stock logo

Celcuity NASDAQ:CELC

$91.98 +2.92 (+3.28%)
As of 04:00 PM Eastern

Celcuity Inc., a clinical stage biotechnology company, focuses on the development of targeted therapies for the treatment of various solid tumors in the United States. The company's CELsignia diagnostic platform uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the related targeted therapy for the treatment. Its drug candidate includes Gedatolisib, which selectively targets various class I isoforms of PI3K and mammalian target of rapamycin and focus on the treatment of patients with hormone receptor positive, HER2-negative, advanced or metastatic breast cancer, and metastatic castration resistant prostate cancer. It had a license agreement with Pfizer, Inc. for the development and commercialization rights to Gedatolisib. The company was founded in 2011 and is headquartered in Minneapolis, Minnesota.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas